Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Current Trends Gynecol Oncol : 9 , Vol 9(1)

Immunotherapy in Omental Cancer: Emerging Treatments and Clinical Trials

Ishag Adam*
Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, United States
*Corresponding Author : Ishag Adam, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, United States, Email: MassaJabra@gmail.com

Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024

Abstract

Omentum cancer, also known as omental cancer, refers to cancer that originates in the omentum, a fold of the peritoneum (the membrane lining the abdominal cavity) that hangs down from the stomach and covers the intestines. The omentum contains fat and is rich in blood vessels, lymphatics, and immune cells. Omentum cancer can either be primary, meaning it starts in the omentum itself, or secondary (metastatic), meaning it spreads to the omentum from another primary cancer site, such as the ovaries, colon, stomach, or pancreas. Symptoms of omentum cancer may include abdominal pain, bloating, nausea, vomiting, weight loss, and changes in bowel habits. Treatment typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the type and stage of the cancer. Early detection and treatment can improve outcomes for individuals with omentum cancer

Citation: Adam I (2024) Immunotherapy in Omental Cancer: Emerging Treatmentsand Clinical Trials. Current Trends Gynecol Oncol, 9: 200.

Copyright: © 2024 Adam I. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top